Zentiva
Martin Lev is a Senior Manager in Corporate Development Strategy at Zentiva since August 2018, overseeing M&A execution with responsibilities including opportunity identification, business planning, and deal structuring. Prior to this role, Martin served as Market and Competitive Intelligence Manager at Zentiva, organizing affiliates to enhance data-driven decision-making. Martin's experience includes a position in Business Excellence at Sanofi, contributing to the company’s leading market position in CZ/SK OTC, and working as a Business & Operations Consultant at Skanska Czech Republic, focusing on organizational strategy and performance analysis. Early career experience includes a role in Assurance at PwC. Martin holds a Master's degree in Corporate Finance & Management and a Bachelor's degree in National Economy and Economic Policies from the University of Economics in Prague.
Zentiva
5 followers
Zentiva is a Pan-European Platform developing, manufacturing and providing high-quality and affordable medicines to more than 100 million people in Europe. Zentiva has 4 wholly owned manufacturing sites and a broad network of external manufacturing partners to ensure supply security. We offer solutions in key therapeutical areas like Cardiology & Circulation, Diabetes, Oncology, Respiratory, CNS and focus on expanding our portfolio in self-care. The company is Private Equity owned, delivering sustainable double-digit growth, with an ambitious 5-year plan for further strong (organic and inorganic) growth across Europe. We are a team of almost 5,000 unique talents bonded together by our mission to deliver high-quality and affordable medicines to people who depend on them every day. We want Zentiva to be a great place to work, where everyone feels welcomed and appreciated and can be their true selves contributing to the best of their ability.